Pulsenmore opened lower at $1.49, compared with its previous close of $1.55. In the last trading session, the stock traded between $1.43 and $1.56. It showed a downward intraday trend.
An investment of $100 made 1 year ago in Pulsenmore is now worth
$ 19.81
Resulting in a loss of
$ 80.19 (80.19%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
$-0.09 (-5.94%)
Day High
$1.56
Day Low
$1.43
Day Open
$1.49
Prev Close
$1.55
Volume
4,948
1W Return
-12.12%
1M Return
-20.54%
3M Return
-54.51%
6M Return
-68.44%
1Y Return
-80.19%
Market Cap ($ Mn)
9
PE Ratio
-
PB Ratio
0.64
PEG Ratio
-
ROE
-19.53%
ROCE
-17.59%
EPS (TTM)
-
1 Week
-12.12%
1 Month
-20.54%
3 Months
-54.51%
6 Months
-68.44%
9 Months
-74.82%
No data available.
Pulsenmore H1 revenue up 53% to ₪6.1M as US ops launch
Revenue grew 53% YoY to ₪6.1 million driven by Clalit sales. Operating loss remained flat at ₪20.8 million despite higher activity. Net financial expenses rose 472% due to warrant accounting. Launched US commercial operations and partnered with Ouma Health.
1mo agoPulsenmore secures CE registration for home fertility ultrasound system
Pulsenmore Ltd completes CE registration for Pulsenmore FC under European MDR rules. System enables home-based ultrasound monitoring for IVF and fertility preservation treatments. Target market includes over 1.15 million assisted reproduction cycles in Europe in 2023. Company expands portfolio to two products, moving beyond prenatal care into fertility.
2mo agoPulsenmore Latest Results: EPS loss widens to $(1.83), sales at $2.042M
Pulsenmore reported a quarterly loss of $(1.83) per share. The company generated sales of $2.042 million during the period. Revenue levels remain modest against the backdrop of per-share losses.
2mo agoPulsenmore leads $1 million AI project in Israel sandbox
Pulsenmore Ltd. was selected by the Israel Innovation Authority and the Ministry of Health to lead a $1 million AI development project under the Healthcare AI Regulatory Sandbox Program. The company will use data from 250,000 home ultrasound scans to validate AI applications that streamline clinical workflows and expand platform scalability. Collaborating with Beilinson Hospital, Pulsenmore aims to address healthcare professional shortages by automating parameter identification and reducing physician review time.
4mo agoPulsenmore raises $7.5 million to fund U.S. expansion
Pulsenmore Ltd. announced a $7.5 million private placement with a single institutional investor, selling shares and warrants at $4.80 each. The proceeds will fund U.S. expansion and working capital. The stock declined 9.41% in premarket trading after a 200% surge earlier in the week.
4mo agoPulsenmore partners with Ouma Health to expand US maternal care access
Pulsenmore Ltd. has partnered with Ouma Health to integrate its FDA-authorized home ultrasound platform into Ouma's virtual maternity care solutions, aiming to address care gaps in underserved US communities. The collaboration allows clinicians to monitor pregnancies remotely, expanding Pulsenmore's presence in the US maternal health market. Following the announcement, Pulsenmore shares rose 204.16% to $10.37 in premarket trading.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 1 year ago in Pulsenmore is now worth
$ 19.81
Resulting in a loss of
$ 80.19 (80.19%)
Note: Past profits do not guarantee future returns.
